34 results on '"Arhin, Francis"'
Search Results
2. Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019
3. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019
4. Analyzing the impact of environmental collaboration among supply chain stakeholders on a firm’s sustainable performance
5. In vitro Activity of Ceftaroline Against Isolates of Gram-Positive Bacteria from Patients with Bloodstream Infections Collected as a Part of ATLAS Between 2017 and 2020.
6. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci
7. In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015
8. Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus
9. Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016–2020.
10. Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus
11. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011–2014
12. Antimicrobial Activity of Ceftazidime–Avibactam and Comparators Against Fluoroquinolone-Resistant Klebsiella pneumoniae Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018–2019.
13. Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes
14. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital
15. Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis
16. Inhibition of transcription in Staphylococcus aureus by a primary sigma factor-binding polypeptide from phage G1
17. A new class of small molecule RNA polymerase inhibitors with activity against Rifampicin-resistant Staphylococcus aureus
18. Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin
19. Time–kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium
20. Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.
21. Outer Membrane Proteins and Serosubtyping with Outer Membrane Vesicles from Clinical Isolates of Neisseria meningitidis
22. Competition of bacteriophage polypeptides with native replicase proteins for binding to the DNA sliding clamp reveals a novel mechanism for DNA replication arrest in Staphylococcus aureus
23. Effects of disruption of xylanase-encoding genes on the xylanolytic system of Streptomyces lividans
24. Cloning, nucleotide sequence and expression in Streptomyces lividans and Escherichia coli of pabB from Lactococcus lactis subsp. lactis NCDO 496
25. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
26. In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene.
27. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus
28. Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus
29. Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis.
30. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
31. Antimicrobial drug discovery through bacteriophage genomics.
32. Supplier sustainability performance evaluation and selection: A framework and methodology.
33. Triaminotriazine DNA helicase inhibitors with antibacterial activity
34. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.